Mario Sciberras – General Manager Cyprus, Malta and Gibraltar, GSK
20.09.2018
Related Interviews
Iacovos Ghalanos – Life Sciences Head, KPMG Cyprus
Healthcare and life science industry advisory services head at KPMG Cyprus, Iacovos Ghalanos, discusses the challenge of implementing the National Health Insurance Scheme, pricing pressures and how their innovative services…
Nicos Anastasiades – President, Republic of Cyprus
In an exclusive interview, President Nicos Anastasiades outlines his public health priorities, the continuing importance of the pharmaceutical industry to Cyprus’s economy, and the nation’s attractiveness as an international investment…
George Campanellas – Director General, Invest Cyprus (Cyprus Investment…
George Campanellas provides an overview of Invest Cyprus’ strategy for attracting foreign investment into Cyprus. He touches on sourcing interest from a wide range of sectors and highlights what makes…
New Special Report on Pharma in Cyprus
With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with…
Cyprus: Sun, Sea and…Surgery?
Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important…
Cyprus Joins the Cannabis Craze
In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the…
Latest Report
